Journal
ADVANCED HEALTHCARE MATERIALS
Volume 5, Issue 20, Pages 2686-2697Publisher
WILEY
DOI: 10.1002/adhm.201600724
Keywords
biomimicry; cardioprotection; monocytes; myocardial infarction; nanomedicines
Funding
- National Research Program for Biopharmaceuticals of the Ministry of Science and Technology [MOST 102-2321-B-001-069, 104-2325-B-001-010]
- Academia Sinica Translational Medicine Program
- Academia Sinica Nanoscience and Nanotechnology Program, Taiwan
Ask authors/readers for more resources
In patients who survive myocardial infarction, many go on to develop congestive heart failure (CHF). Despite ongoing efforts to develop new approaches for postinfarction therapy, there are still no effective therapeutic options available to CHF patients. Currently, the delivery of cardioprotective drugs relies entirely on passive uptake via the enhanced permeability and retention (EPR) effect which occurs in proximity to the infarction site. However, in ischemic disease, unlike in cancer, the EPR effect only exists for a short duration postinfarction and thus insufficient for meaningful cardioprotection. Splenic monocytes are recruited to the heart in large numbers postinfarction, and are known to interact with platelets during circulation. Therefore, the strategy is to exploit this interaction by developing platelet-like proteoliposomes (PLPs), biomimicking platelet interactions with circulating monocytes. PLPs show strong binding affinity for monocytes but not for endothelial cells in vitro, mimicking normal platelet activity. Furthermore, intravital multiphoton imaging shows that comparing to plain liposomes, PLPs do not aggregate on uninjured endothelium but do accumulate at the injury site 72 h postinfarction. Importantly, PLPs enhance the targeting of anti-inflammatory drug, cobalt protoporphyrin, to the heart in an EPR-independent manner, which result in better therapeutic outcome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available